Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
申请人:Abbott Laboratories
公开号:US08338466B2
公开(公告)日:2012-12-25
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
本发明涉及一些化合物,其抑制抗凋亡Bcl-2蛋白的活性,包含这些化合物的组合物以及治疗在其中表达抗凋亡Bcl-2蛋白的疾病的方法。